Syllable Stock

Syllable uses AI to transform the way healthcare systems initiate and cultivate relationships with patients.

Sign up today and learn more about Syllable Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Syllable Stock

Syllable is an AI powered healthcare services company that transforms the way healthcare systems initiate and cultivate relationships with patients. Long call hold times, rerouted or dropped calls and misinformation can all contribute to a frustrating patient experience and make it cumbersome to access vital care quickly. Syllable helps patients navigate their journey to health with empathy, transparency and intelligence from the moment they request care by dialing the phone or visiting a healthcare system’s website. Founded in 2016, Syllable’s solutions are in use by some of the largest and most respected healthcare providers across America.

Investors

Funding History

March 2017$4.3M
September 2018$9.7M
June 2021$28.0M
February 2022$40.0M

Management

Co founder

Andrew Rogers

Director of Product

Ibrahim Cotran

Chief Commercial Officer

Tom McCormick

Co founder & COO

Gui Bastos

Board Member

Vig Chandramouli

CEO

Kobus Jooste

Software Engineer

Raphael Cendrillon

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo